LITIGATION (Including Hatch-Waxman and BCPIA)
Green Griffith litigators have handled cases throughout the United States, including all of the district courts known for deciding major patent cases, as well as the Federal Circuit and the United States Supreme Court. As a result, our attorneys have broad knowledge of all phases of patent litigation from pre-litigation counseling through Markman hearings, dispositive motions, jury trials, and appeals.
We have decades of experience in litigating patent and trade secret cases, especially with respect to cases brought pursuant to the Hatch-Waxman Act, where we represent both brand and generic pharma companies. Our extensive experience with pharmaceutical litigation informs our strategy for litigating patent challenges with respect to biologics as well.
founding partner of Green Griffith, Chris has practiced law over 35 years, specializing in IP litigation and counseling services across the pharmaceutical, chemical, medical device, and biotech industries. He has an impressive history of representing clients as lead counsel in U.S. district courts across the country, the Court of Appeals for the Federal Circuit, and as local counsel on patent cases in the Northern District of Illinois (Member, Trial Bar) – the latter being a judicial district that has a unique set of local patent rules and practices.
Chris’s expertise in contentious matters is not limited to the courtroom. He has represented clients in Inter Partes Reviews (IPR) under the AIA, and in many arbitration and mediation proceedings.
While he advises clients across a broad spectrum of technologies, Chris possesses unique expertise on Orange Book and related FDA issues affecting pharmaceuticals, particularly those arising under the Hatch-Waxman Act, and issues affecting biologics and biosimilars under the BPCIA.